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The Structure of the Ligand-Binding Domain
of Neurexin Ib: Regulation of LNS Domain Function
by Alternative Splicing
domains (site #2, #3, and #4) and accomodate insertions
of up to 30 amino acids. At least some of the alternative
splicing is spatially regulated in brain, resulting in a spe-
cific regional distribution of neurexin isoforms (Ullrich
et al., 1995).
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So far, three ligands of neurexins have been identified,³Center for Basic Neuroscience and
all of which interact with LNS domains. The exogenousDepartment of Molecular Genetics
ligand a-latrotoxin, a neurotoxin from black widow spi-University of Texas Southwestern Medical Center
der venom, triggers massive neurotransmitter releaseDallas, Texas 75235-9050
upon binding (Rosenthal and Meldolesi, 1989). Two en-
dogenous ligands are known as well: neuroligins, brain-
specific cell adhesion molecules (Ichtchenko et al.,Summary
1995, 1996); and neurexophilins, brain-specific mole-
cules resembling neuropeptides (Petrenko et al., 1996;Neurexins are expressed in hundreds of isoforms on
Missler and SuÈ dhof, 1998b). Single LNS domains arethe neuronal cell surface, where they may function
sufficient for ligand binding. b-neurexin containing aas cell recognition molecules. Neurexins contain LNS
sole LNS domain binds a-latrotoxin and neuroligin (Icht-domains, folding units found in many proteins like the
chenko et al., 1995; Sugita et al., 1999). The sixth LNSG domain of laminin A, agrin, and slit. The crystal struc-
domain of a-neurexin (which is the counterpart toture of neurexin Ib, a single LNS domain, reveals two
b-neurexin) binds a-latrotoxin but not neuroligin (Sugitaseven-stranded b sheets forming a jelly roll fold with
et al., 1999), while the second LNS domain of a-neurexinunexpected structural similarity to lectins. The LNS
alone is sufficient for binding to neurexophilin (Misslerdomains of neurexin and agrin undergo alternative
and SuÈ dhof, 1998b). Binding of neuroligin and a-latro-splicing that modulates their affinity for protein ligands
toxin is tightly controlled by alternative splicing at sitein a neuron-specific manner. These splice sites are
#4, localized in the single LNS domain shared by a- andlocalized within loops at one edge of the jelly roll,
b-neurexins.suggesting a distinct protein interaction surface in
The ability of b-neurexins to interact with neuroliginsLNS domains that is regulated by alternative splicing.
results in a clear biological function. b-neurexin is lo-
cated on the presynaptic membrane, and neuroligins
are clustered in the postsynaptic density (Missler andIntroduction
SuÈ dhof, 1998a; Song et al., 1999). By virtue of their extra-
cellular interaction, b-neurexins and neuroligins estab-Neurexins are brain-specific cell surface proteins that
lish an intercellular junction (Nguyen and SuÈ dhof, 1997)are synthesized in hundreds of isoforms (Ushkaryov et
that may coincide with synaptic junctions (Butz et al.,al., 1992; Ullrich et al., 1995; Missler and SuÈ dhof, 1998a).
1998; Song et al., 1999). Intracellularly, the C-terminalIt is thought that each of the different neurexins interacts
cytoplasmic tails of b-neurexins and neuroligins bindwith specific protein ligands contributing to neuron:
proteins containing PDZ domains (Hata et al., 1996; Irieneuron recognition and neuron:neuron adhesion. The
et al., 1997). Ion channels and neurotransmitter recep-neurexin genes direct the synthesis of two products,
tors are recruited by these PDZ domain±containing pro-
a-neurexins and b-neurexins, which differ in the size of
teins as well (Kim et al., 1995; Kornau et al., 1995), so
their extracellular domains but have identical transmem-
that the interaction between b-neurexin and neuroligin
brane regions and cytoplasmic tails (Ushkaryov et al.,
not only bridges the connection between two synaptic
1992, 1994; Ushkaryov and SuÈ dhof, 1993). The extracel- membranes but also brings the pre- and postsynaptic
lular regions of neurexins contain LNS domains, found machinery in proximity to each other.
in the G domain of Laminin A (Deutzmann et al., 1988), Alternative splicing of LNS domains in agrin, a heparan
Neurexins (Ushkaryov et al., 1992; Missler and SuÈ dhof, sulfate proteoglycan found in the extracellular matrix
1998a), and serum proteins such as Sex hormone± (ECM), also regulates function (Ferns et al., 1993). When
binding globulins (Joseph and Baker, 1992). LNS do- deposited by nerve terminals of motor neurons, neural
mains are present in many extracellular proteins, includ- agrin promotes pre- and postsynaptic specializations
ing agrin, slit, perlecan, and laminins (Joseph and Baker, at neuromuscular junctions by inducing clustering of
1992; Timpl and Brown, 1994; Missler and SuÈ dhof, acetylcholine receptors (Kleiman and Reichardt, 1996).
1998a). a-neurexins contain three EGF-like repeats and In nonnervous tissue, agrin may be important for me-
six LNS domains in their extracellular region, while chanical stability through interactions with proteogly-
b-neurexins contain only a single LNS domain that is cans in the ECM (Gesemann et al., 1998). Insertion of
identical with the sixth LNS domain of a-neurexins. The short amino acid sequences at site z in the third LNS
primary transcripts of neurexins are alternatively spliced domain of agrin by alternative splicing activates acetyl-
at five canonical positions. Three of these are in LNS choline receptor clustering (Ruegg and Bixby, 1998;
Sanes et al., 1998). Splicing at the y site in agrin, located
in the second LNS domain, alters its glycan/proteogly-§ To whom correspondence should be addressed (e-mail: johann.
deisenhofer@email.swmed.edu). can specificity (Ferns et al., 1993). Single LNS domains
Cell
94
of agrin are also sufficient for ligand binding. The second
LNS domain of agrin alone binds heparin, while the third
LNS domain is sufficient for acetylcholine receptor clus-
tering (Campagnelli et al., 1996; Gesemann et al., 1996).
The activities of these domains are controlled by incor-
poration of the correct splice inserts (Campagnelli et al.,
1996; Gesemann et al. 1996), and splicing is also strictly
tissue specific; for example, only the neuronal form of
agrin contains inserts at both sites y and z (Hoch et al.,
1993; Gesemann et al., 1996) and can promote synapse
formation.
In the current study, we have attempted to gain insight
into the structural basis of the function of LNS domains
and their regulation by alternative splicing through struc-
ture determination of neurexin Ib.
Results
Structure Determination
Native crystals of the extracellular domain of neurexin
Ib diffract high-brilliance synchrotron radiation to 2.6 AÊ
resolution. Initial phases were obtained by multiwave-
length anomalous dispersion (MAD) techniques on the
seleno-methionine variant of neurexin Ib, but noncrys-
tallographic symmetry (NCS) averaging was necessary
to obtain interpretable electron density (Figure 1). The
asymmetric unit contained eight neurexin Ib molecules,
with only one ordered methionine per monomer (Met-
271). The model was subsequently refined using eight-
fold NCS restraints to a resolution of 2.6 AÊ , resulting in
an Rfree value of 28.0% and an Rwork value of 24.5%. Data
collection and refinement statistics are summarized in
Table 1.
There are extensive crystal contacts between the neu-
rexin Ib molecules. The asymmetric unit contains two
clusters of four molecules, arranged around a two-fold
NCS screw axis that is parallel to the crystallographic
c axis. Each cluster is made up of two pairs of neurexin
Ib molecules, related by an approximate two-fold NCS
axis. The most extensive interactions are between adja-
cent monomers, related by a rotation of 1308±1358. Be-
cause neurexin Ib behaves as a monomer in solution
based on size exclusion chromatography, the interac-
tions observed in the crystal are probably a direct result
of the crystal packing and therefore do not describe a
physiologically relevant oligomeric state of neurexin Ib.
In all eight neurexin Ib molecules, residues 84±289 are
visible in the electron density. The residue numbering
has been kept consistent with Ushkaryov et al. (1994),
where residues 1±46 correspond to the signal sequence,
and the numbering includes the 30±amino acid insert
that is found at splice site #4 in neurexin Ib. The signal Figure 1. MAD Phasing and Noncrystallographic Averaging
sequence, the insert at site #4, and a stretch of O-linked The positions of eight selenium atoms (yellow) and four palladium
glycosylated polypeptide just prior to the transmem- atoms (magenta) in the asymmetric unit (A). A two-fold screw axis
brane segment are not present in the protein used for parallel to the crystallographic c axis relates two groups of four
selenium atoms. A four-fold relationship is found between groupsthe structure determination. The N- and C-terminal se-
each containing two selenium atoms and a palladium atom. Thequences of the eight molecules in the asymmetric unit
electron density (contoured at 1.5 s) is shown as obtained from theare disordered to varying degrees, with up to 6 residues
MAD phases alone (B). The electron density was improved by four-
visible from residue 84 toward the N terminus, and up fold NCS averaging enabling model building (data not shown). The
to 11 residues visible from residue 289 toward the C final density obtained by phase combination of the refined model
terminus. Thus, the structure covers the entire LNS do- and eight-fold averaging is shown in (C). The difference density for
Se-Met-271 is shown in yellow (B and C).main of neurexin Ib.
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Table 1. Summary of the Data Collection, Phasing, and Refinement Statistics
Data Collection and Phasing Statistics
Total Reflections/ Phasing Rcullisd
Resolution (AÊ ) l (AÊ ) Unique Completeness (%) Rsymb (%) I/s Sites Powerc (iso/ano)
Native 20±2.6 (2.64±2.6)a 1.07124 351,083/73,128 98.1(82.7) 9.5(49.5) 17.4(3.1)
MAD analysis
Sepeak 43±3.0 (3.05±3.0) 0.97912 282,246/44,365 93.0(82.8) 9.4(38.4) 17.2(3.7) 8 0.87 0.88/0.84
Seinflection 49±3.3 (3.36±3.3) 0.97928 254,362/36,384 97.5(89.2) 10.6(39.9) 17.4(4.3) Ð Ð Ð/0.95
Overall figure of merit to 3.0 AÊ : 0.30
MIR analysis
Pd 43±3.2 (3.26±3.2) 0.92206 128,037/35,517 87.7(34.9) 10.9(22.2) 10.6(3.0) 4 0.66 0.93/Ð










Rmsd bond lengths 0.015 AÊ
Rmsd bond angles 1.908
Rmsd between NCS-related molecule 0.51 AÊ (175 Ca atoms) and 0.12 AÊ (149 Ca atoms)
0.78 AÊ (1,319 atoms) and 0.16 AÊ (1,139 atoms)
Average B of main chain atoms 33.8 AÊ 2
Average B of side chain atoms 35.4 AÊ 2
Average B of solvent 28.1 AÊ 2
aStatistics for the outer shell are in parentheses.
bRsym 5 ShSi| |Ih,i 2 ,Ih. |/ Sh Si Ih,I
cPhasing power 5 ,Fh./e
dRcullis 5 e/Diso, where e is the lack of closure.
The phasing power and Rcullis are calculated for data between 15 AÊ and the resolution limit given in column 1 (upper panel).
Overall Fold to each b sheet (b1/b2, b2/b3, b3/b4, b7/b8, b10/b11,
b11/b12, and b13/b14), whereas five pairs (b4/b5, b5/The neurexin Ib LNS domain is composed of 14 b strands
and one a helix and has a globular shape (Figure 2). The b6, b6/b7, b8/b9, and b9/b10) contribute both strands
to the same sheet (Figure 2C). The N and C termini14 b strands form two antiparallel seven-stranded b
sheets in a jelly roll fold (Figures 2A and 2B). Seven pairs belong to the outer strands of one end of the jelly roll
and are located near each other in space. The a helixof strands adjacent in sequence contribute one strand
Figure 2. Overall Structure and Topology of Neurexin Ib
Ribbon diagram of the neurexin 1b monomer shown (A) perpendicular to the b sheets and (B) rotated by 908 around a vertical axis. Secondary
structure elements, assigned using DSSP (Kabsch and Sander, 1983), are labeled together with loops referred to in the text. The connectivities
are visualized in a topology diagram (C) derived from the program TOPS written by Westhead et al. (http://www3.ebi.ac.uk/tops/). Arrows
represent b strands, and a circle depicts the a helix. Connectivities are given in gray lines. The variable and conserved parts of the fold are
indicated as discussed in the text.
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Table 2. Structural Homologs to Neurexin Ib
Concave Sheet Convex Sheet
Protein Caa Rmsd (AÊ ) bb bc bb bc Known Function; Ligands
Serum Amyloid P 157 2.3 7 7 7 7 Binds amyloid fibrils, DNA, fibronectin,
glycosaminoglycans; X-ray structure known
with galactopyranoside (1sac-A, Emsley et
al., 1994)
Tetanus toxin Hc 146 2.9 7 7 7 7 Neurotoxin working at neuromuscular
lectin domain junction; function of the lectin domain not
known (1a8d, Umland et al., 1997)
1,3-1,4-b-glucanase 147 3.1 7 7 7 7 Cleaves 1,4-b-D-glucosidic bonds; X-ray
structure known with b-D-cellobioside (1 axk,
AyÈ et al., 1998, Keitel et al., 1993)
Sialidase w1 (V. cholerae) 81 1.8 7 7 6 6 Lectin domains w1 and w2 may promote
Sialidase w2 76 2.2 7 7 6 6 adhesion to epithelial cells (1kit, Crennell
et al., 1994)
Cellobiohydrolase I 67 2.4 9 6 7 7 Hydrolysis of native crystalline cellulose;
X-ray structure known with cellobioside
derivative (1cel, Divne et al., 1994)
Lectin IV 73 2.8 7 7 6 6 X-ray structure known with Lewis b blood
group determinant (1led, Delbaere et al.,
1993)
S-lectin 67 3.2 6 6 5 5 Suggested binding to extracellular
matrix proteins; X-ray structure known
with N-acetyllactosamine (1slt, Liao
et al., 1994)
aThe number of Ca atoms used in the superposition of b sheets. The structures had a Z score greater than 3.5 in DALI (Holm and Sander,
1993).
bNumber of b strands forming the b sheet
cNumber of b strands with structurally equivalent counterparts in neurexin Ib.
The PDB entry code is given in parentheses in the last column.
is located between b strands b12 and b13. The two b Conserved Structure of LNS Domains
Alignment of various LNS domain sequences with neu-sheets are approximately parallel and curved, producing
rexin Ib reveals a low but significant overall similarity.a large concave surface on one side (concave sheet) and
Figure 4 shows a sequence comparison of the six LNSa convex surface on the opposite side (convex sheet). A
domains from rat neurexin Ia with the five LNS domainsdepression is formed on the concave face of the protein
from human laminin a-1 and the three LNS domains ofby loops connecting b strands, which rise up from the
rat agrin. Significant sequence similarity is observededges of the b sheet to form two walls. A long b arch
only between the regions corresponding to b strandsbetween b11 and b12 juts up over the concave face to
b3±b12 in neurexin Ib. The N- and C-terminal flankingform the upper wall, and the loop connecting strands
sequences corresponding to b strands b1, b2, b13, andb4 and b5 forms the lower wall (Figure 2B).
b14 in neurexin Ib are divergent, suggesting that they
may adopt different conformations, or that in some LNS
Neurexin Ib Is Structurally Similar to Lectins domains equivalent elements may not be present at all.
Topological and three-dimensional comparisons reveal As a result, LNS domains appear to be composed of a
that the structure of neurexin Ib is similar to lectins conserved core containing two five-stranded b sheets
and lectin-like domains (see Table 2, Figure 3). These (b3 through b12), and a variable part containing se-
proteins include Ca21-(in)-dependent lectins, serum am- quences that correspond to b strands b1, b2, b13, and
yloid P protein (a pentraxin), glucanases, and cellulases, b14 in neurexin Ib.
as well as lectin-like domains found in tetanus toxin and The highest degree of sequence identity between LNS
some neuraminidases. Neurexin Ib is structurally closest domains is found in short loops between the b strands.
to the serum amyloid P protein (Table 2). Despite the In the 14 LNS sequences in Figure 4, the most highly
very low sequence identity (,15%), the hallmarks of the conserved residues are Gly residues located in short
lectin fold are maintained: a pair of antiparallel b sheets loops between b strands (residues aligned with A124,
curved to form a concave and a convex side. Many of G146, G155, D157, G246, G247, and G265). Many of the
the proteins listed in Table 2 bind sugars, and sugar- residues participating in the hydrophobic core located
binding residues have been identified crystallographi- between the two sheets are semiconserved (L113, I115,
cally through structure determination of protein:carbo- V125, L126, V127, L139, I148, V150, V176, I244, I245,
hydrate complexes. The sugar-binding sites in these and Y263). The greatest variability among LNS domains
proteins are all located on the surface of the concave is observed in the longer loops. A special structural
sheet, with loops protruding from the edges of the sheet feature of neurexin Ib is a salt bridge between Asp-111
rising up to provide ligand-binding residues and partici- and Arg-180, which is buried in between the two b sheets
pating in forming the walls of the substrate-binding and links the b strands b3 and b8. In many neurexins,
including neurexin Ib, the residues Asp-170, His-174,pocket (Figure 3) (Weis and Drickamer, 1996).
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Figure 4. Sequence Alignment of LNS Domains in Neurexins, Lami-
nin G, and Agrin
LNS domains from rat neurexin Ia are labeled consecutively N1, N2,
N3, N4, and N5 in the order they appear in the amino acid sequence.
Neurexin Ib (nIb) is identical to the sixth LNS domain in neurexin
1a. The five laminin A, G domain repeats from human (accession
No. P25391) are labeled L1, L2, L3, L4, and L5; repeats found in
rat agrin (accession No. AAA40702) are labeled A1, A2, and A3.
Alternatively spliced sites in neurexin LNS domains (site #2, #3, and
#4) and agrin repeats (agrin y and agrin z) are indicated. The integrin-
binding RGD sequence found in L3 (the G3 repeat of human laminin
A) is underlined in orange. b strands (blue arrows) and the a helix
Figure 3. Structural Similarity between Neurexin Ib and Lectin (magenta bar) refer to the structure of neurexin Ib. Regions that are
Domains expected to share a similar structure are shaded in light green,
The neurexin Ib structure (A) is compared to serum amyloid P protein whereas unshaded regions indicate high sequence variability and
(PDB ID code: 1sac [B]), glucanase (1axk [C]), and S-lectin (1slt [D]). uncertainty of the fold. Residue numbering for neurexin Ib is ac-
A ribbon diagram (left) visualizes b strands in light blue or yellow cording to Ushkaryov et al. (1994).
and helices in magenta or green. Loops rising up over the concave
surface forming part of the sugar binding pockets in 1sac, 1axk,
and 1slt are shown in red, and their counterparts in neurexin Ib
function, we mapped known splice sites onto the three-are indicated as well. The molecular surfaces (right) are colored
according to electrostatic potential with blue corresponding to 110 dimensional structure of neurexin Ib, aided by the se-
kT and red corresponding to 210 kT. Arrows indicate the carbohy- quence alignment shown in Figure 4. Although the sites
drate-binding sites identified in the crystal structures. are far apart in sequence, they are all located in loops
at the bottom side of the b sheets as shown in Figure
5. The position of the splice sites suggests that insertsand Asp-190 form a highly conserved cluster located
on the surface at the edge of the two sheets, with the probably do not affect the overall jelly roll fold but modu-
late the structure of surface loops.histidine sandwiched between the two aspartate resi-
dues. Hydrogen bonds between these residues mediate Splice site #2 is located in the loop between b8 and
b9, where inserts of 8 or 15 amino acids have beenthe interactions between the b arch b7-b8 and the hair-
pin/tight turn b9-b10, likely stabilizing the fold in addition identified (e.g., HSGIGHAM, HSGIGHAMVNKLHCS; Ull-
rich et al., 1995). Inserts of 1, 10, or 13 amino acids haveto keeping the side chains in a fixed orientation with
respect to each other and to the solvent. been identified at splice site #3 (e.g., G, DCIRINCNSS,
DCLRVGCAPT, DCLRVGCAPSAAA; Ullrich et al., 1995),
which is located in the loop between strands b6 andStructural Basis for the Regulation of LNS Domains
by Alternative Splicing b7. Inserts at these two positions probably extend the
loop structure. Alternatively, the sequences inserted atThe large number of neurexins expressed in the brain
arises by alternative splicing (Ullrich et al., 1995). To site #3 could potentially replace strand b7, since there
is some sequence similarity between the longer insertsexplore how alternative splicing may regulate LNS domain
Cell
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Figure 5. Alternative Splice Sites
Stereo Ca trace of neurexin Ib. Alternative splice sites identified in neurexin LNS domains are labeled #2, #3, #4, two sites identified in agrin
LNS domains are labeled Y and Z. The equivalent position of the RGD sequence in human laminin A, implicated in integrin binding, is labeled
with L.
found here and strand b7. Splice site #4 in neurexin Ib change of electrostatic properties, since it would intro-
duce three charged residues at the protein surface. At(equivalent to the sixth LNS domain in neurexin Ia) has
been studied the most extensively. So far, there is only site z in the third LNS domain, the presence of a splice
insert enables agrin to induce acetylcholine receptorone single insert known for this site: the 30±amino acid
sequence GNNDNERLAIARQRIPYRLGRVVDEWLLDK clustering (Ferns et al., 1993) probably by activating a
tyrosine kinase (Kleiman and Reichardt, 1996). Splice(Ushkaryov et al., 1994). Neurexin Ib is able to bind to
neuroligin and a-latrotoxin only when no insert is present inserts of 8, 11, or 19 amino acids have been identified
in site z (Figure 4) in various organisms (McMahan etat splice site #4. Site #4 is located in the long loop
connecting b10 and b11. Because of its size, the insert al., 1992). Site z is localized in the sequence immediately
N-terminal to the well-conserved b strand b3 in neurexinmay introduce additional secondary structure elements.
The secondary structure prediction programs PhD (Rost Ib, which is at the boundary between the conserved
core and the regions of high variability in the LNS foldand Sander, 1994) and nnPredict (Kneller et al., 1990)
suggest that these 30 amino acids can form two helices (Figures 2C and 4). Site z, like site y, maps to a loop in
the neurexin Ib structure and is found close to the othersimilar to a polypeptide stretch of approximately 20
amino acids found in cellobiohydrolase I that is located alternative splicing sites (Figure 5).
The loops that harbor neurexin site #4 and agrin siteat a similar position in the fold. In cellobiohydrolase I,
these residues form a two-helix bundle oriented perpen- z participate in protein:protein interactions and thus ap-
pear to constitute a protein interaction surface. In thedicular to the sheets, packed against a strand equivalent
to b7 in neurexin Ib so that the helices create the bound- case of agrin, the presence of an insert at site z promotes
protein complex formation, whereas in neurexin Ib atary wall of one end of the cellulose-binding pocket. Be-
cause the 30±amino acid insert at site #4 blocks binding site #4 it abolishes binding of its known ligands. The
surface containing the splice sites does not coincideof neurexin Ib to neuroligin and a-latrotoxin, it is likely
that protein-binding sites for these two ligands involve with the conserved location of carbohydrate-binding
pockets on the concave sheet observed in lectins. How-loop b10-b11.
Agrin, like the neurexins, undergoes alternative splic- ever, the fact that site y in agrin, which modulates affinity
to heparan sulfate, coincides with site #4 in neurexin,ing in its LNS domains regulating function. The presence
of the four±amino acid insert KSRK at site y in the second which regulates binding to protein ligands, does indicate
that the protein interaction surface is spatially closeLNS domain of agrin activates binding to highly nega-
tively charged heparan sulfate. At the same time, how- to the carbohydrate binding area and underscores the
multifunctional characteristics of LNS domains.ever, presence of this insert greatly diminishes the affin-
ity for a-dystroglycan, a component of the dystrophin
complex that mediates interactions between the extra- Discussion
cellular matrix and the membrane cytoskeleton (Campa-
nelli et al., 1996; Gesemann et al., 1996). The amino acid LNS domains are sequence motifs found in a large,
diverse set of extracellular proteins. This set includessequence of the insert at site y is found to be invariable
in all organisms examined. Splice site y is located in a components of the extracellular matrix (a-laminins, per-
lecan), molecules with a developmental signaling func-position structurally equivalent to splice site #4 in neu-
rexin Ib, in a loop between b10 and b11 (Figure 5). In tion (agrin, crumbs, slit, Gas6), cell surface proteins in-
volved in cell adhesion (neurexins and neurexin-likeagrin, the KSRK insert most likely results in a drastic
Neurexin Ib Ligand-Binding Domain Structure
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proteins, NG2), and serum components (sex hormone± can be arranged like pearls on a string with the protein
binding globulin, protein S). LNS domains often occur interaction surface exposed to the environment.
in multiple copies probably serving as general protein
Experimental Proceduresinteraction domains that bind to target proteins and
other macromolecules, such as carbohydrates. In most
Protein Expression and Purificationproteins, the precise function of LNS domains is un-
The extracellular domain of rat neurexin Ib without an insert at siteknown. A large number of ligands for the LNS domains in
#4 and without its signal sequence (residues 47±302, numbering by
the G domain of a-laminins has been reported, including Ushkaryov et al., 1994) was overexpressed in E. coli BL21 as a
heparin, sulfatides, integrins, dystroglycan, nidogen, glutathione S-transferase (GST) fusion protein linked by a thrombin
and fibulin (Talts et al., 1999), but the specificity of most cleavage site (Nguyen and SuÈ dhof, 1997). Cells were lysed with
lysozyme (1 mg/ml in 20 mM Tris [pH 8.0], 2 mM EDTA, 1 mM DTT,of these interactions is unknown. In neurexins, the func-
0.1 mM PMSF) and sonication. The lysate was incubated for 45 mintions of two LNS domains have been defined via their
on ice with 20 mg/ml DNase and 5 mM MgCl2, followed by additionligands neurexophilins, a-latrotoxin, and neuroligins,
of 7 mM EDTA. Addition of 1% (v/v) Triton X-100 to the lysateand binding is tightly regulated by alternative splicing.
increased the final yield. After centrifugation at 20,000 rpm (Sorvall
The structure of the LNS domain is very similar to SS-34 rotor, 30 min, 48C), the supernatant was incubated overnight
lectin(-like) proteins, in particular, serum amyloid pro- with glutathione-agarose beads in 20 mM Tris (pH 8.0), 150 mM
tein, S-lectin, and glucanase, all shown to bind sugars. NaCl, 2 mM EDTA, 1 mM DTT, 0.1% (v/v) Triton X-100. The GST-
neurexin Ib fusion protein was cleaved off the beads using 4 U/mlIn agrin and a-laminins, LNS domains bind to heparin
thrombin. The supernatant was applied to a Mono Q column andand other glycosaminoglycan components of the extra-
equilibrated in 20 mM Tris (pH 8), 30 mM NaCl. The flow throughcellular matrix. The LNS domains in neurexins, however,
was dialyzed against 50 mM sodium phosphate (pH 6.0), 2 mMare not known to bind carbohydrates. The structural
EDTA, 10% (v/v) glycerol then applied to a Mono S, equilibrated
homology between neurexin Ib and lectins raises the with the same buffer, and eluted at 300 mM NaCl. The protein was
possibility that LNS domains may have a general func- lastly subjected to size exclusion chromatography (Superdex75) in
tion as carbohydrate-binding modules, and that in neu- 20 mM HEPES (pH 7.5), 150 mM NaCl, and 1 mM EDTA. The seleno-
methionine variant of neurexin Ib was produced by overexpressionrexins, protein:carbohydrate interactions might contrib-
of neurexin Ib in B834(DE3) cells in minimal medium in the presenceute to their cell-adhesive properties at neuronal
of 25 mg/l L-seleno-methionine. The seleno-methionine variant wasjunctions. While it remains to be investigated whether
purified using the same protocol as for the wild protein with theLNS domains in neurexins do indeed bind sugars, their
exception that all buffers contained 1 mM DTT. Mass spectrometric
interactions with protein ligands are well characterized. analysis confirmed the incorporation of two seleno-methionine resi-
There is no question that at least some of these domains dues per neurexin Ib molecule.
are involved in high-affinity protein:protein interactions.
Crystallization and X-Ray Data CollectionFor example, neurexin Ib binds a-latrotoxin with pico-
Both the wild-type and the seleno-methionine variant of neurexinmolar affinity (Sugita et al., 1999). This interaction is not
Ib were crystallized by vapor diffusion at 218C. Drops contained 6mediated by sugars because a-latrotoxin is not glycosy-
ml of protein (10 mg/ml in 20 mM HEPES [pH 7.5], 150 mM NaCl,lated.
and 1m M EDTA), 2 ml 15% 1,2,3-heptanetriol, and 8 ml reservoir
Arguably, the most interesting aspect of the binding solution (21% [w/v] PEG 5000 MME, 100 mM sodium cacodylate
of neurexins to a-latrotoxin and neuroligin is the tight [pH 6.5], 200 mM ammonium sulfate). Single crystals grew as thin
regulation of these interactions by alternative splicing. plates with average dimensions of 0.3 3 0.25 3 0.005 mm. The
crystals have the symmetry of space group P21212, with cell con-This regulatory mechanism is not unique to neurexins
stants of a 5 116.6 AÊ , b 5 195.9 AÊ , c 5 103.6 AÊ . Crystal densitybecause the interaction of agrin with its ligands is also
measurements failed to reveal unequivocally the content of thecontrolled by alternative splicing in the LNS domains
asymmetric unit (data not shown). The Matthews coefficient (Mat-(Ferns et al., 1993). When we mapped the sites of alter-
thews, 1968) indicates 4±8 molecules per asymmetric unit. Potential
native splicing in neurexins and agrin onto the three- heavy atom derivatives were prepared by soaking crystals in reser-
dimensional structure of the LNS domain of neurexin Ib, voir solution containing heavy atom compounds. Prior to data col-
they localized to the same surface of the LNS domain lection, crystals were cryoprotected with reservoir solution con-
taining 30% (v/v) glycerol and flash-cooled in liquid propane.in loops, although the sites are far apart in the primary
The largest crystals diffracted weakly to about 3.5 AÊ Bragg spac-sequence (Figures 4 and 5). All splice sites are found at
ing, when using a conventional rotating anode X-ray source. There-the edge of the jelly roll at the bottom of the LNS domain
fore, the use of synchrotron radiation was critical for the structureas shown in Figure 5, suggesting that the region defined
determination of neurexin Ib. Collection of native data and heavy
by these sites constitutes a ligand interaction surface atom derivative screening were carried out at the National Synchro-
and is a major site of regulation. The hypothesis that tron Light Source (NSLS) beamlines X12-B, X12-C, and X25; at the
this region might be a site of protein:protein interaction Stanford Synchrotron Radiation Laboratory (SSRL) beamlines 1±5
and 9±1; and at the Advanced Photon Source (APS) beamline 19-ID,in many other LNS domains is supported by the observa-
where the MAD experiment using crystals of the seleno-methioninetion that the integrin-binding RGD sequence found in
variant of n1b was also done. Two data sets, one at the seleniumthe human a-laminin LNS domain G3 (Haaparanta et al.,
absorption peak (12663.0 eV) and one at the inflection point (12660.91991) also maps to this region (Figures 4 and 5). As a eV), were collected before radiation damage drastically reduced the
result, we propose that LNS domains can function as diffraction quality of the crystal. Diffraction data were integrated
general protein:protein interaction domains whose bind- and reduced using HKL2000 (Otwinowski and Minor, unpublished
ing activities involve this surface. LNS domains are data), DENZO/SCALEPACK (Otwinowski and Minor, 1997), and
MOSFLM (Leslie, 1992). The data were further scaled using pro-unique compared to other universal globular protein in-
grams from the CCP4 suite (Collaborative Computing Project 4,teraction domains, such as EGF-like sequences, immu-
1994). Data collection statistics are summarized in Table 1.noglobulin folds, or fibronectin III repeats, in that their
binding properties appear to be regulated by alternative MAD Phasing, Noncrystallographic Symmetry Averaging,
splicing, which changes the surface of the protein bind- and Structure Refinement
ing interface. Since the binding interface is located op- Selenium sites were identified with Shake 'n Bake B 2.0 (Smith et
al., 1998) using data collected at the selenium absorption peak. Theposite to the N and C termini, multiple LNS domains
Cell
100
selenium parameters were refined, then phases were calculated Pannu, N.S., et al. (1998). Crystallography and NMR system: a new
software suite for macromolecular structure determination. Actawith MLPHARE (Otwinowski, 1991), using the inflection point data
Crystallogr. D 54, 905±921.set as a reference data set, and improved by density modification
with DM (Cowtan, 1994). Since neurexin Ib contains two methionine Butz, S., Okamoto, M., and SuÈ dhof, T.C. (1998). A tripartite protein
residues, we assumed four molecules in the asymmetric unit. By complex with the potential to couple synaptic vesicle exocytosis to
inspection of the selenium positions using FINDNCS (Lu, 1999), only cell adhesion in brain. Cell 94, 773±782.
a two-fold noncrystallographic screw axis parallel to the crystallo- Campanelli, J.T., Gayer, G.G., and Scheller, R.H. (1996). Alternative
graphic c axis could be unequivocally identified (Figure 1). NCS RNA splicing that determines agrin activity regulates binding to
averaging using this operator did not significantly improve the elec- heparin and a-dystroglycan. Development 122, 1663±1672.
tron density. It was therefore attempted to improve the MAD phases
Collaborative Computational Project, Number 4. (1994). The CCP4by incorporating additional phase information from heavy atom de-
suite: programs for protein crystallography. Acta Crystallogr. D 50,rivatives. Four palladium sites could be identified in a palladium
760±763.derivative. Difference-Fourier techniques were used to select sites
Cowtan, K. (1994). ªDMº: an automated procedure for phase im-that obeyed the additional constraints that potential heavy atom
provement by density modification. In Joint CCP4 and ESF-EACBMpositions obeyed the two-fold NCS screw operation derived from
Newsletter on Protein Crystallography. 31, 34±38.the selenium positions (Figure 1A). These additional constraints en-
Crennell, S., Garman, E., Laver, G., Vimr, E., and Taylor, G. (1994).abled us to identify correct sites, even though they did not signifi-
Crystal structure of Vibrio cholerae neuraminidase reveals dual lec-cantly stand out above the noise. The palladium sites obtained
tin-like domains in addition to the catalytic domain. Structure 2,were critical for the identification of noncrystallographic symmetry
535±544.operators, but they could not be further used in the phasing due to
severe nonisomorphism. After the initial model was built in four-fold Delbaere, L.T.J., Vandonselaar, M., Prasad, L., Quail, J.W., Wilson,
averaged electron density maps, it became clear that there were in K.S., and Dauter, Z. (1993). Structures of the Lectin IV of Griffonia
fact eight molecules in the asymmetric unit, with only one out of simplicifolia and its complex with the Lewis b human blood group
two methionines ordered per monomer, while only four molecules determinant at 2.0 AÊ . J. Mol. Biol. 230, 950±965.
out of eight contained palladium sites that we could identify. Seleno- Deutzmann, R., Huber, J., Schmetz, K.A., Oberbaumer, I., and Hartl,
methionine 295, which is disordered, is located on the C-terminal L. (1988). Structural study of long arm fragments of laminin. Evidence
stretch of approximately ten amino acids, which is not visible in for repetitive C-terminal sequences in the A-chain, not present in
the crystal structure. The electron density was further improved by the B-chains. Eur. J. Biochem. 177, 35±45.
eight-fold averaging. The initial atomic model was refined with the
Divne, C., StaÊ hlberg, J., Reinikainen, T., Ruohonen, L., Pettersson,
program CNS (BruÈ nger et al., 1998) against the combined maximum- G., Knowles, J.K.C., Teeri, T.T., and Jones, T.A. (1994). The three-
likelihood and experimental phase target (MLHL), using all data from dimensional crystal structure of the catalytic core of cellobiohydro-
the best native data set (collected at APS beamline 19-ID) between lase I from Trichoderma reesei. Science 265, 524±528.
20 and 2.6 AÊ . Refinement included eight-fold NCS restraints, overall
Emsley, J., White, H.E., O'Hara, B.P., Oliva, G., Srinivasan, N., Tickle,anisotropic B factor calculation, and bulk solvent correction. Refine-
I., Blundell, T.L., Pepys, M.B., and Wood, S.P. (1994). Structurement steps were accepted only when they produced a decrease in
of pentameric human serum amyloid P component. Nature 367,the Rfree value. The eight-fold NCS restraints allowed calculation of
338±345.individual B factors. The current model contains 1449 residues and
Esnouf, R.M. (1999). Further additions to MolScript version 1.4, in-71 well-ordered solvent molecules. Residue Asp-190 is the only
cluding reading and contouring of electron density maps. Acta Crys-residue found in the forbidden region of the Ramachandran plot,
tallogr. D 55, 938±940.but both the backbone as well as the side chain of this residue
make extensive hydrogen bonds to the protein. Current refinement Ferns, M.J., Campanelli, J.T., Hoch, W., Scheller, R.H., and Hall, Z.
statistics are listed in Table 1. Structural comparisons were carried (1993). The ability of agrin to cluster AChRs depends on alternative
splicing and on cell surface proteoglycans. Neuron 11, 491±502.out with DALI (Holm and Sander, 1993). The sequence alignment
was prepared with ClustalW (Higgins et al., 1996), and then manually Gesemann, M., Cavalli, V., Denzer, A.J., Brancaccio, A., Schu-
refined based on the structural information of neurexin Ib. The fig- macher, B., and Ruegg, M.A. (1996). Alternative splicing of agrin
ures were generated with the programs O (Jones et al., 1991), RAS- alters its binding to heparin, dystroglycan, and the putative agrin
TER3D (Merritt and Bacon, 1997), GRASP (Nicholls et al., 1991), receptor. Neuron 16, 755±767.
MOLSCRIPT (Kraulis, 1991), BOBSCRIPT (Esnouf, 1999), and Gesemann, M., Brancaccio, A., Schumacher, B., and Ruegg, M.A.
gl_render (L. Esser, unpublished data). (1998). Agrin is a high-affinity binding protein of dystroglycan in non-
muscle tissue. J. Biol. Chem. 273, 600±605.
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